FMP
NASDAQ
1.05 USD
-0.035 (-3.33%)
Mr. John K. Celebi M.B.A.
Healthcare
Biotechnology
https://www.senseibio.com
NASDAQ
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the tre...
0001829802
US81728A1088
81728A108
451 D Street
240 243 8000
US
28
Feb 4, 2021
0001829802
NASDAQ
Biotechnology
Healthcare
81728A108
US81728A1088
US
1.05
0.09
55.97k
26.32M
-
0.51-1.926
0.24
-
-
-
-
-0.86
-
https://www.senseibio.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.